ScoreWhy is Ishita Drugs & Industries Ltd ?
1
Weak Long Term Fundamental Strength with a -2.09% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.79
- The company has been able to generate a Return on Equity (avg) of 8.40% signifying low profitability per unit of shareholders funds
2
Negative results in Mar 26
- NET SALES(Latest six months) At Rs 6.20 cr has Grown at -28.65%
- PBDIT(Q) Lowest at Rs 0.10 cr.
- PBT LESS OI(Q) Lowest at Rs 0.06 cr.
3
With ROE of 7.2, it has a Expensive valuation with a 2.3 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 1.62%, its profits have fallen by -9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ishita Drugs for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Ishita Drugs
1.62%
0.03
57.56%
Sensex
-8.84%
-0.68
13.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
1.01%
EBIT Growth (5y)
-2.09%
EBIT to Interest (avg)
0.79
Debt to EBITDA (avg)
1.49
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
1.44
Tax Ratio
28.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
36.73%
ROE (avg)
8.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
31
Industry P/E
33
Price to Book Value
2.26
EV to EBIT
19.92
EV to EBITDA
19.92
EV to Capital Employed
3.14
EV to Sales
1.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.04%
ROE (Latest)
7.23%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-6What is not working for the Company
NET SALES(Latest six months)
At Rs 6.20 cr has Grown at -28.65%
PBDIT(Q)
Lowest at Rs 0.10 cr.
PBT LESS OI(Q)
Lowest at Rs 0.06 cr.
Loading Valuation Snapshot...
Here's what is not working for Ishita Drugs
Net Sales - Latest six months
At Rs 6.20 cr has Grown at -28.65%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 0.10 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.06 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
